22 Results for "

gastric inhibitory peptide

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "gastric inhibitory peptide" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-P0276
CAS No.: 100040-31-1
Synonyms: gastric inhibitory peptide (GIP), human
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP, human, a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP, human acts as an incretin hormone released from intestinal K cells in response to nutrient ingestion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0276A
Synonyms: gastric inhibitory peptide (GIP), human TFA
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP, human TFA, a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP, human TFA acts as an incretin hormone released from intestinal K cells in response to nutrient ingestion .
loading...
    loading...
Cat. No.: HY-P3579
CAS No.: 11063-17-5
Synonyms: GIP (1-42), porcine
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Gastric Inhibitory Peptide (GIP (1-42)), porcine is a porcine glucose-dependent insulinotropic polypeptide and inhibitor of pentagastrin-stimulated gastric acid secretion. Gastric Inhibitory Peptide, porcine stimulates endogenous somatostatin release. Gastric Inhibitory Peptide, porcine acts in a dose- and time-dependent manner in conscious, chronic gastric fistula-equipped rats .
loading...
    loading...
Cat. No.: HY-P11271
CAS No.: 2940971-65-1
Research Areas:  

Metabolic Disease

Ribupatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .
loading...
    loading...
Cat. No.: HY-P3580A
Synonyms: Human N-acetyl GIP TFA
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease Endocrinology

Acetyl Gastric Inhibitory Peptide (human) TFA is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Acetyl Gastric Inhibitory Peptide (human) TFA can be used for research of diabetes, insulin resistance and obesity .
loading...
    loading...
Cat. No.: HY-P3584A
Synonyms: (Pro3) gastric inhibitory peptide, human TFA
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

(Pro3) GIP, human TFA is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human TFA has high binding affinity for human GIPR with Ki/ Kd value of 0.90 nM. (Pro3) GIP, human TFA human can be used for the research of obesity-related diabetes .
loading...
    loading...
Cat. No.: HY-P10591
CAS No.: 2675496-01-0
Synonyms: Olatorepatidum; HS-20094
Research Areas:  

Metabolic Disease

Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist, with antidiabetic effect .
loading...
    loading...
Cat. No.: HY-P11271A
Research Areas:  

Metabolic Disease

Ribupatide TFA is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Ribupatide TFA can be studied in antidiabetic research .
loading...
    loading...
Cat. No.: HY-P3584
CAS No.: 299898-52-5
Synonyms: (Pro3) gastric inhibitory peptide, human
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes .
loading...
    loading...
Cat. No.: HY-P3580
CAS No.: 299898-33-2
Synonyms: Human N-acetyl GIP
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease Endocrinology

Acetyl Gastric Inhibitory Peptide (human) is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Acetyl Gastric Inhibitory Peptide (human) can be used for research of diabetes, insulin resistance and obesity .
loading...
    loading...
Cat. No.: HY-103545
CAS No.: 725474-97-5
Synonyms: gastric inhibitory peptide (1-39) (porcine)
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP (1-39) (Gastric inhibitory peptide (1-39) (porcine)) is an insulinotropic peptide that stimulats insulin secretion from rat pancreatic islets. GIP (1-39) at 100 nM was able to significantly increase intracellular Ca 2+ concentration ([Ca 2+]i), and capable of enhancing exocytosis .
loading...
    loading...
Cat. No.: HY-P11270
CAS No.: 2843676-09-3
Synonyms: BGM0504; BG128
Research Areas:  

Metabolic Disease

Relsipatide (BG128) is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .
loading...
    loading...
Cat. No.: HY-P3577
CAS No.: 121765-67-1
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research .
loading...
    loading...
Cat. No.: HY-P10952
CAS No.: 2959444-13-2
Research Areas:  

Metabolic Disease

Astepatide is a gastric inhibitory peptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in anti-diabetic research .
loading...
    loading...
Cat. No.: HY-P3578
CAS No.: 134875-67-5
Target:  

Insulin Receptor

Research Areas:  

Endocrinology

Gastric Inhibitory Polypeptide (1-30), porcine lacks the C-terminal 12 amino acid residues of natural gastric inhibitory polypeptide (GIP), exhibits biologic activity by potentiating the release of insulin and somatostatin .
loading...
    loading...
Cat. No.: HY-P0165B
CAS No.: 1022150-16-8
Synonyms: ITM077 acetate; R1583 acetate; BIM51077 acetate
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Taspoglutide (R1583) acetate is an agonist of the glucagon-like peptide 1 receptor (GLP-1R) with an Ki value of 1.1 nM. Taspoglutide acetate induces cAMP accumulation in CHO-K1 cells expressing human GLP-1R (EC50 = 0.06 nM). Taspoglutide acetate decreases blood levels of glucose and increases blood levels of insulin in a glucose tolerance test in Zucker diabetic obese rats. Taspoglutide acetate reduces blood levels of gastric inhibitory polypeptide (GIP), plasma levels of triglycerides, and body weight in the same model .
loading...
    loading...
Cat. No.: HY-P12133
CAS No.: 3080063-21-1
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Tapimtrutide is a gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Tapimtrutide can be used for the research of diabetes .
loading...
    loading...
Cat. No.: HY-P11666
CAS No.: 2408921-49-1
Synonyms: LY-3537031
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Brenipatide (LY-3537031) is a dual glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor agonist. Brenipatide can be used for the study of metabolic disorders, obesity and diabetes .
loading...
    loading...
Cat. No.: HY-P11674
CAS No.: 3060140-36-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Zantrutide is a glucagon, gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Zantrutide can be used for the study of metabolic diseases .
loading...
    loading...
Cat. No.: HY-P12134
CAS No.: 3056608-43-3
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Zormapatide is a gastric inhibitory polypeptide (GIP) receptor agonist peptide. Zormapatide contains 2-methylalanine residues and an N 6-[N-(19-carboxynonadecanoyl)-L-γ-glutamyl-L-lysyl] modification. Zormapatide is applicable to the research of diabetes and metabolic diseases .
loading...
    loading...